301 | 5PIT |
Lysine-specific demethylase 4D | Homo sapiens |
Q6B0I6 (KDM4D_HUMAN) |
N-OXALYLGLYCINE |
OGA |
|
0.55 |
SHOW |
302 | 5PHB |
Lysine-specific demethylase 4D | Homo sapiens |
Q6B0I6 (KDM4D_HUMAN) |
N-OXALYLGLYCINE |
OGA |
|
0.52 |
SHOW |
303 | 3DXU |
Lysine-specific demethylase 4D | Homo sapiens |
Q6B0I6 (KDM4D_HUMAN) |
N-OXALYLGLYCINE |
OGA |
|
0.52 |
SHOW |
304 | 6ETE |
Lysine-specific demethylase 4D | Homo sapiens |
Q6B0I6 (KDM4D_HUMAN) |
[2-(1-methyl-1,2,3,4-tetrazol-4-ium-5-yl)ethanoylamino]azanium |
BWK |
|
0.51 |
SHOW |
305 | 6ETT |
Lysine-specific demethylase 4D | Homo sapiens |
Q6B0I6 (KDM4D_HUMAN) |
ethyl 2-(2~{H}-1,2,3,4-tetrazol-5-yl)ethanoate |
BXH |
|
0.47 |
SHOW |
306 | 6X4D |
Gag-Pol polyprotein | Human immunodeficiency virus type 1 group M subtype B |
P03366 (POL_HV1B1) |
5-(cyclopropylmethyl)-7-{2-[2-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)ethoxy]phenoxy}-8-methylnaphthalene-2-carbonitrile |
UO4 |
|
0.42 |
SHOW |
307 | 6DTW |
Gag-Pol polyprotein | Human immunodeficiency virus type 1 group M subtype B |
P03366 (POL_HV1B1) |
8-{2-[2-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)ethoxy]-4-fluorophenoxy}-6-fluoroindolizine-2-carbonitrile |
H9Y |
|
0.41 |
SHOW |
308 | 5PH9 |
Lysine-specific demethylase 4D | Homo sapiens |
Q6B0I6 (KDM4D_HUMAN) |
N-OXALYLGLYCINE |
OGA |
|
0.41 |
SHOW |
309 | 4MPO |
Nudix hydrolase domain-containing protein | Chlamydia trachomatis serovar L2 |
A0A0H3MCJ9 (A0A0H3MCJ9_CHLT2) |
ADENOSINE MONOPHOSPHATE |
AMP |
|
0.41 |
SHOW |